Skip to main content
!
Updates on the University COVID-19 response and operations available here.
!
Updates on the University COVID-19 response and operations available here.
!
Updates on the University COVID-19 response and operations available here.
Displaying 1123 of 2776 articles.
>

New technique captures unprecedented view of the active brain

The tech, dubbed MesoLF, captures 10,500 neurons buried at once-inaccessible depths, firing from brain regions many millimeters apart, simultaneously—all with unprecedented resolution.

Innovative approach opens the door to COVID nanobody therapies

The relatively simple and low-cost procedure could empower laboratories in low-resource areas to generate nanobodies against SARS-CoV-2, as well as other viruses.

Illuminating the evolution of social parasite ants

The findings offer a new way to understand how some ants become total layabouts.

Homing in on the genetics of severe COVID in children

A trio of faulty genes fail to put the brakes on the immune system’s all-out assault on SARS-CoV-2, leading to the inflammatory overload characteristic of MIS-C.

The nutrient that cancer cells crave

Starving cancer cells of a key amino acid could potentially render tumors more vulnerable to the body’s natural immune response.

A unique window into "original antigenic sin"

The body's first blush with a pathogen shapes how it will respond to vaccines. New evidence clarifies how this phenomenon works, mechanistically.

How the body's B cell academy ensures a diverse immune response

A diverse immune response hinges on naive B cells mingling with high affinity ones in the late-stage germinal center. Whether that helps or hinders, however, depends on the virus.

Why older fathers pass on more genetic mutations to their offspring

It's not just the number of mutations that matters. It's the failure to fix them too.

>

Solving a crucial bottleneck in drug discovery

A novel method reduces the time required to identify novel antibiotic-producing DNA from weeks to days.

When the body's B cell training grounds stay open after hours

While most germinal centers shut down after a few weeks, some stay in business for more than six months. A new study helps explain why.
View
View